Mouthwash may shield cancer patients from painful drug side effect
NCT ID NCT06974604
Summary
This study is testing if a steroid mouthwash can prevent painful mouth sores, a common side effect of a cancer drug called datopotamab deruxtecan. It will enroll 60 adults with advanced breast or lung cancer who are receiving this drug. The main goal is to see if using the mouthwash for the first few treatment cycles lowers the rate of mouth sores by 20%.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rhode Island and the Miriam Hospitals (Brown University Health)
RECRUITINGProvidence, Rhode Island, 02903/02906, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.